Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Saas

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
Frontiers in Immunology|June 24, 2021
New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory ResponseHanane Adda-Rezig, Clémence Carron, Jean-Paul Pais de Barros, et al.
Ejhaem|August 22, 2025
Venetoclax in the Therapeutic Strategy for BPDCN ManagementMargaux Poussard, Maxime Fredon, Imane Belakri, et al.
Frontiers in Immunology|March 29, 2022
Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHDClaire Gérard, Marine Thébault, Baptiste Lamarthée, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy responseYann Godet, Elizabeth Fabre, Magalie Dosset, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2015
Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytesNona Janikashvili, Malika Trad, Alexandrine Gautheron, et al.
Ejhaem|July 18, 2022
BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicityMargaux Poussard, Laure Philippe, Maxime Fredon, et al.
Frontiers in Immunology|March 10, 2023
Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritisMaxime Samson, Coraline Genet, Marc Corbera-Bellalta, et al.
Journal of Autoimmunity|November 20, 2016
B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopeniaSylvain Audia, Marzia Rossato, Malika Trad, et al.
British Journal of Haematology|April 25, 2009
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemiaFrancine Garnache-Ottou, Jean Feuillard, Christophe Ferrand, et al.
Journal of Autoimmunity|May 17, 2021
Mucosal-associated invariant T cells in Giant Cell ArteritisThibault Ghesquière, Marion Ciudad, André Ramon, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
Frontiers in Immunology|June 24, 2021
New Insights on End-Stage Renal Disease and Healthy Individual Gut Bacterial Translocation: Different Carbon Composition of Lipopolysaccharides and Different Impact on Monocyte Inflammatory ResponseHanane Adda-Rezig, Clémence Carron, Jean-Paul Pais de Barros, et al.
Ejhaem|August 22, 2025
Venetoclax in the Therapeutic Strategy for BPDCN ManagementMargaux Poussard, Maxime Fredon, Imane Belakri, et al.
Frontiers in Immunology|March 29, 2022
Human Monocyte-Derived Suppressor Cell Supernatant Induces Immunoregulatory Effects and Mitigates xenoGvHDClaire Gérard, Marine Thébault, Baptiste Lamarthée, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2012
Analysis of spontaneous tumor-specific CD4 T-cell immunity in lung cancer using promiscuous HLA-DR telomerase-derived epitopes: potential synergistic effect with chemotherapy responseYann Godet, Elizabeth Fabre, Magalie Dosset, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2015
Human monocyte-derived suppressor cells control graft-versus-host disease by inducing regulatory forkhead box protein 3-positive CD8+ T lymphocytesNona Janikashvili, Malika Trad, Alexandrine Gautheron, et al.
Ejhaem|July 18, 2022
BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicityMargaux Poussard, Laure Philippe, Maxime Fredon, et al.
Frontiers in Immunology|March 10, 2023
Human monocyte-derived suppressive cells (HuMoSC) for cell therapy in giant cell arteritisMaxime Samson, Coraline Genet, Marc Corbera-Bellalta, et al.
Journal of Autoimmunity|November 20, 2016
B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopeniaSylvain Audia, Marzia Rossato, Malika Trad, et al.
British Journal of Haematology|April 25, 2009
Extended diagnostic criteria for plasmacytoid dendritic cell leukaemiaFrancine Garnache-Ottou, Jean Feuillard, Christophe Ferrand, et al.
Journal of Autoimmunity|May 17, 2021
Mucosal-associated invariant T cells in Giant Cell ArteritisThibault Ghesquière, Marion Ciudad, André Ramon, et al.
Pageof 21